World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02477137
Date of registration: 12/06/2015
Prospective Registration: Yes
Primary sponsor: Karolinska Institutet
Public title: Effects of an Interactive ICT-Platform for Assessment and Management of Symptoms in Patients Treated for Prostate Cancer PhONEME
Scientific title: PhONEME - PartipatOn Ehealth MobilE. Effects of an Interactive Information and Communications Technology (ICT) Platform for Assessment and Management of Symptoms in Patients Treated for Prostate Cancer
Date of first enrolment: July 20, 2015
Target sample size: 150
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02477137
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Single Group Assignment. Primary purpose: Supportive Care. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
Sweden
Contacts
Name:     Ann Langius-Eklöf, RN, PhD
Address: 
Telephone:
Email:
Affiliation:  Karolinska Institutet
Key inclusion & exclusion criteria

Inclusion Criteria:

- Diagnosis of prostate cancer without metastases or spread to the lymph nodes,

- will receive radiation therapy for at least five (5) weeks,

- literacy in the Swedish language

Exclusion Criteria:

- Patients who need an interpreter at the doctor's visit

- Patients who have a known severe cognitive impairment



Age minimum: 18 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Prostate Cancer
Intervention(s)
Device: smartphone or tablet
Primary Outcome(s)
Questionnaire Sense of Coherence Scale (KASAM) [Time Frame: up to 3 months after completion of radiotherapy treatment]
Scale for Communicative and Critical Health Literacy (S-C & C HL - Swedish version) [Time Frame: up to 3 months after completion of radiotherapy treatment]
European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC-QLQ-C30) [Time Frame: up to 3 months after completion of radiotherapy treatment]
EORTC Prostate-specific module (QLQ-PR25) Questionnaire [Time Frame: up to 3 months after completion of radiotherapy treatment]
Questionnaire Individualized Care Scale (ICS) [Time Frame: up to 3 months after completion of radiotherapy treatment]
Questionnaire Scale for Functional Health Literacy (S-FHL - Swedish version) [Time Frame: up to 3 months after completion of radiotherapy treatment]
Secondary Outcome(s)
Health care costs [Time Frame: up to 3 months after completion of radiotherapy treatment]
Secondary ID(s)
PhONEME Prostate
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Karolinska University Hospital
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history